Literature DB >> 9605371

Increased platelet microvesicle formation is associated with mortality in a porcine model of endotoxemia.

M Eriksson1, D Nelson, A Nordgren, A Larsson.   

Abstract

BACKGROUND: Gram-negative sepsis in humans and endotoxemia in pigs induce the formation of platelet microvesicles. These microvesicles are active in homeostasis and may thus contribute to the outcome in patients with activated coagulation and fibrinolysis. We decided to prospectively evaluate the effects of endotoxemia on microvesicle formation and some common physiologic variables against survival in a porcine model.
METHODS: Nineteen included pigs were anesthetized, monitored and subjected to an infusion of E. coli endotoxin. Microvesicle formation was determined by flow cytometry.
RESULTS: The formation of microvesicles was significantly increased in the 6 pigs that died during endotoxin exposure. This increased formation became significant from the 3rd hour of endotoxemia. Microvesicle formation did not increase in surviving endotoxemic pigs. Cardiac index, mean arterial blood pressure, base excess and systemic vascular resistance index were distinctly reduced in the animals that died as compared to those surviving the endotoxemic period.
CONCLUSION: The increased formation of platelet microvesicles seems to be associated with poor prognosis in porcine endotoxemia. Since microvesicles are active in coagulation, they may contribute to the derangement of the coagulation system caused by endotoxemia. Different degrees of microvesicle formation may reflect inter-individual responses to a given challenge.

Entities:  

Mesh:

Year:  1998        PMID: 9605371     DOI: 10.1111/j.1399-6576.1998.tb05165.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  7 in total

Review 1.  Microvesicles at the crossroads between infection and cardiovascular diseases.

Authors:  Jing Xiong; Virginia M Miller; Yunman Li; Muthuvel Jayachandran
Journal:  J Cardiovasc Pharmacol       Date:  2012-02       Impact factor: 3.105

2.  Therapeutic Potential of Extracellular Vesicles for Sepsis Treatment.

Authors:  Stephanie M Kronstadt; Alex E Pottash; Daniel Levy; Sheng Wang; Wei Chao; Steven M Jay
Journal:  Adv Ther (Weinh)       Date:  2021-04-29

3.  Leukocyte- and platelet-derived microvesicle interactions following in vitro and in vivo activation of toll-like receptor 4 by lipopolysaccharide.

Authors:  Jing Xiong; Virginia M Miller; Larry W Hunter; Yunman Li; Muthuvel Jayachandran
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

Review 4.  Microparticles: a new perspective in central nervous system disorders.

Authors:  Stephanie M Schindler; Jonathan P Little; Andis Klegeris
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

Review 5.  Extracellular vesicles as mediators and markers of acute organ injury: current concepts.

Authors:  Birte Weber; Niklas Franz; Ingo Marzi; Dirk Henrich; Liudmila Leppik
Journal:  Eur J Trauma Emerg Surg       Date:  2021-02-03       Impact factor: 3.693

6.  HMGB1/IL-1β complexes in plasma microvesicles modulate immune responses to burn injury.

Authors:  Leon G Coleman; Robert Maile; Samuel W Jones; Bruce A Cairns; Fulton T Crews
Journal:  PLoS One       Date:  2018-03-30       Impact factor: 3.240

Review 7.  Extracellular Vesicles as Markers and Mediators in Sepsis.

Authors:  Pierre Raeven; Johannes Zipperle; Susanne Drechsler
Journal:  Theranostics       Date:  2018-05-23       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.